Challenges in biomarker-based clinical trials for patients with gastrointestinal malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges in biomarker-based clinical trials for patients with gastrointestinal malignancies

Published:2022-01-02 Issue:1 Volume:7 Page:121-130
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Kratz Jeremy D.¹²³,Zhang Wei¹⁴,Patel Monica¹²,Uboha Nataliya V.¹²

Affiliation:

1. Carbone Cancer Center, University of Wisconsin, Madison, WI, USA

2. Division of Hematology, Medical Oncology and Palliative care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA

3. US Department of Veterans Affairs, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA

4. Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA

Funder

University of Wisconsin Carbone Cancer Center

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2022.2106852

Reference75 articles.

1. Tissue-Agnostic Drug Development

2. Tissue-agnostic cancer drug pipeline grows, despite doubts

3. Biomarkers in early-phase trials: fundamental issues

4. Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use

5. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP